Erratum: The development of a redox-sensitive curcumin conjugated chitosan oligosaccharide nanocarrier for the efficient delivery of docetaxel to glioma cells

Erratum to: Ann Transl Med 2022;10:297.

The article (1) titled “The development of a redox-sensitive curcumin conjugated chitosan oligosaccharide nanocarrier for the efficient delivery of docetaxel to glioma cells” (doi: 10.21037/atm-22-288) unfortunately contains errors in Figures 5,6. The wrong images were uploaded for Figures 5E,6A.

The corrected Figures 5E,6A are presented below:

Figure 5 (E) Histological H&E staining of the major organs excised from tumor-bearing mice treated with NS, Taxotere^®, DTX/CSO-cc-CUR nanoparticles, DTX/CSO-ss-CUR nanoparticles (scale bar: 200 µm).

Figure 6 (A) Real-time fluorescence images of living mice following treatment with free DiR and DiR/CSO-ss-CUR through tail vein injection.

The authors regretted the errors and confirmed they did not compromise the integrity of the data, results, or conclusions of the research.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Liu C, Gao Y, Zhao L, et al. The development of a redox-sensitive curcumin conjugated chitosan oligosaccharide nanocarrier for the efficient delivery of docetaxel to glioma cells. Ann Transl Med 2022;10:297. [Crossref] [PubMed]